CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
1.660
-0.090 (-5.14%)
Oct 30, 2026, 10:43 AM EDT - Market open
CervoMed Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 22.46 | 8.24 | 9 | 7.79 | 4.09 | 6.67 |
Short-Term Investments | 2.48 | 12.63 | 29.92 | - | - | - |
Cash & Short-Term Investments | 24.94 | 20.86 | 38.92 | 7.79 | 4.09 | 6.67 |
Cash Growth | -25.63% | -46.39% | 399.46% | 90.37% | -38.59% | - |
Accounts Receivable | - | 0.43 | 2.25 | 0.92 | - | - |
Other Receivables | - | - | - | - | - | 0.07 |
Receivables | - | 0.43 | 2.25 | 0.92 | - | 0.07 |
Prepaid Expenses | 0.73 | 1.27 | 1.91 | 1.26 | 0.06 | 0.02 |
Other Current Assets | 0.32 | 0.32 | - | - | - | 0.05 |
Total Current Assets | 25.99 | 22.88 | 43.08 | 9.96 | 4.16 | 6.82 |
Other Long-Term Assets | - | - | - | 0.01 | - | - |
Total Assets | 25.99 | 22.88 | 43.08 | 9.97 | 4.16 | 6.82 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.69 | 1.45 | 1.51 | 0.66 | 0.1 | 0.02 |
Accrued Expenses | 2.29 | 3.12 | 2.25 | 1.84 | 0.59 | 0.4 |
Current Portion of Long-Term Debt | - | - | - | - | 12.41 | 4.11 |
Other Current Liabilities | 0.05 | 0.08 | 0.12 | 0.09 | 0.05 | 0.03 |
Total Current Liabilities | 3.03 | 4.66 | 3.88 | 2.6 | 13.16 | 4.56 |
Long-Term Debt | - | - | - | - | - | 5.92 |
Total Liabilities | 3.03 | 4.66 | 3.88 | 2.6 | 13.16 | 10.47 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0 | 0 |
Additional Paid-In Capital | 135.18 | 115.91 | 109.87 | 61.81 | 18.98 | 18.52 |
Retained Earnings | -112.23 | -97.7 | -70.73 | -54.44 | -52.27 | -46.47 |
Comprehensive Income & Other | 0 | 0.01 | 0.06 | - | - | - |
Total Common Equity | 22.96 | 18.22 | 39.2 | 7.38 | -33.29 | -27.94 |
Shareholders' Equity | 22.96 | 18.22 | 39.2 | 7.38 | -9 | -3.66 |
Total Liabilities & Equity | 25.99 | 22.88 | 43.08 | 9.97 | 4.16 | 6.82 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | - | - | - | - | 12.41 | 10.03 |
Net Cash (Debt) | 24.94 | 20.86 | 38.92 | 7.79 | -8.32 | -3.36 |
Net Cash Growth | -25.63% | -46.39% | 399.46% | - | - | - |
Net Cash Per Share | 2.62 | 2.31 | 4.82 | 2.93 | -16.06 | -0.75 |
Filing Date Shares Outstanding | 15.12 | 9.26 | 8.7 | 6.17 | 4.5 | 4.5 |
Total Common Shares Outstanding | 13.53 | 9.25 | 8.7 | 5.67 | 4.5 | 4.5 |
Working Capital | 22.96 | 18.22 | 39.2 | 7.37 | -9 | 2.26 |
Book Value Per Share | 1.70 | 1.97 | 4.50 | 1.30 | -7.39 | -6.21 |
Tangible Book Value | 22.96 | 18.22 | 39.2 | 7.38 | -33.29 | -27.94 |
Tangible Book Value Per Share | 1.70 | 1.97 | 4.50 | 1.30 | -7.39 | -6.21 |